Allelic Variations of Glut-1 Deficiency Syndrome: The Chinese Experience

详细信息	查看全文 | 推荐本文 |

• 作者：Yanyan Liu ; MD^a ; ^b ; Xinhua Bao ; MD^a ; ^{zwhang@pku.edu.cn} ; Dong Wang ; MD^c ; Na Fu ; MD^a ; Xiaoying Zhang ; MD^a ; Guangna Cao ; MD^a ; Fuying Song ; MD^b ; Shuang Wang ; MD^a ; Yuehua Zhang ; PhD^a ; Jiong Qin ; MD^a ; Hong Yang ; MD^c ; Kristin Engelstad ; MS^c ; Darryl C. De Vivo ; MD^c ; Xiru Wu ; MD^a
• 刊名：Pediatric Neurology
• 出版年：2012
• 期刊代码：218_08878994
• 类别：med
• 出版时间：July, 2012
• 卷：47
• 期：1
• 页码：30-34
• 文件大小：362 K

摘要

Glucose transporter type 1 deficiency syndrome is characterized by infantile onset seizures, development delay, movement disorders, and acquired microcephaly. The phenotype includes allelic variants such as intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia of childhood with or without epilepsy. Dystonias involve allelic variants of glucose transporter type 1 deficiency syndrome. Three Chinese patients presented with paroxysmal behavioral disturbance, weakness, ataxia (especially after fasting), and exercise intolerance. Electroencephalogram findings did not correlate with clinical manifestations. Cranial magnetic resonance imaging produced normal results or mild hypomyelination. Hypoglycorrhachia was evident in all cases. Cerebrospinal fluid glucose ranged from 1.63-2.45 mmol/L. Erythrocyte 3-O-methyl-d-glucose uptake was decreased to 58%in patient 1. Three SLC2A1 disease-causing mutations (761delA, P383H, and R400C) were observed. No patient tolerated ketogenic diets. Two patients responded to frequent meals with snacks. Cerebrospinal fluid evaluation constitutes the diagnostic testing permitting early treatment of glucose transporter type 1 deficiency syndrome. Early diagnosis and treatment improve prognoses.